Capital IntelligencePlatform

Close Your Round Faster.
With Intelligence, Not Instinct.

CIP is the capital advisory infrastructure Future Ventures Capital uses to match growth-stage companies with the right institutional investors — scored, ranked, and ready to engage. Access it through our Sprint program or as a licensed advisory partner.
18,000+
Institutional Investors
$3M–$50M
Target Transaction Range
5-Dimension
Capital Readiness Score
4 Weeks
Sprint to Market-Ready

How CIP Works

Three integrated systems that take a company from capital readiness assessment to investor-ready in four weeks.
Capital Readiness Score
Five-dimension scoring model that evaluates your company against institutional investor expectations. Identifies gaps before they become deal-killers.
Investor Matching
AI-powered fit scoring against 18,000+ institutional investors — filtered by stage, sector, geography, check size, and active deployment status. Note: this count covers institutional firms; the number of individual investors within those firms is higher.
Sprint-to-Close Workflow
Structured four-week process from company intake to investor-ready deliverables. Used in every FVC advisory engagement.

Who Accesses CIP

CIP is not a self-serve tool. It is accessed through two pathways — both designed to maximize the probability of a successful raise.
GROWTH-STAGE COMPANIES

Approaching a $2M–$50M+ Institutional Round

Access CIP through the FVC Sprint — a four-week capital preparation program that scores your company, refines your narrative, and delivers a ranked investor target list of 50–75 institutional fits.
BOUTIQUE CAPITAL ADVISORS

Running Multiple Mandates Without Institutional Infrastructure

License CIP as your advisory operating system. Manage multiple client mandates with deal scoring, investor matching, tiered CIM output, and EOI-to-close workflow — all under your brand.

Ready to Raise Smarter?

The Sprint is a four-week fixed engagement. We take you from company intake to a scored, investor-targeted, pitch-ready package. Cohort availability is limited.